Loading...
Market
What will be the adoption rate of prenatal blood tests for cancer detection in North America by end of 2025?
2
Resolution / Starting Odds
Less than 10% • 25%
10% to 30% • 25%
30% to 50% • 25%
More than 50% • 25%
Reports or studies from healthcare institutions or research organizations
Story
NEJM Study: Prenatal Blood Test May Detect Hidden Cancers in 1 in 2 Pregnant Women
Dec 5, 2024, 11:45 AM
A study published in the New England Journal of Medicine (NEJM) has revealed that prenatal blood tests, specifically cell-free DNA (cfDNA) sequencing for fetal aneuploidy, can sometimes indicate the presence of hidden cancers in pregnant women. The IDENTIFY study found that among 107 participants with unusual or nonreportable results from these tests, approximately half were diagnosed with an occult cancer. Most of the genetic variants detected were copy number variations (CNVs) across multiple chromosomes. The study was conducted by commercial laboratories in North America and highlights the potential of prenatal testing to alert healthcare providers to maternal health issues beyond fetal conditions.
View original story
Similar markets
Less than 20% • 25%
20%-40% • 25%
40%-60% • 25%
More than 60% • 25%
Yes • 50%
No • 50%
High adoption (75%+ countries) • 25%
Moderate adoption (50-74% countries) • 25%
Low adoption (25-49% countries) • 25%
Minimal adoption (<25% countries) • 25%
Less than 10% • 25%
10% to 25% • 25%
25% to 50% • 25%
More than 50% • 25%
0-10% • 25%
11-25% • 25%
26-50% • 25%
51%+ • 25%
Yes • 50%
No • 50%
Below 10% • 25%
10% - 20% • 25%
20% - 30% • 25%
Above 30% • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
Market share increases • 25%
Market share remains the same • 25%
Market share decreases • 25%
Foresight exits cancer-detection market • 25%
Less than 10% • 25%
10%-20% • 25%
20%-30% • 25%
More than 30% • 25%
Yes • 50%
No • 50%
Widely adopted (>75% of clinics) • 25%
Moderately adopted (50-75% of clinics) • 25%
Sparsely adopted (25-50% of clinics) • 25%
Rarely adopted (<25% of clinics) • 25%